Clinical trials: Posttransplant Diabetes Mellitus
Diabetes Mellitus, Kidney Failure
Prospective Controlled Study of Posttransplant Diabetes
Research participants will be asked to undergo complete medical history, physical examination and blood tests. The purpose of these tests is to determine whether persons are predisposed to develop diabetes mellitus after kidney…
- Trial name
- NCT00006331
- Testing
- renal transplant
- Where
- United States
- Sponsor
- National Center for Research Resources (NCRR)
Posttransplant Diabetes Mellitus, Acute Graft Rejection
Silymarin's Advantage on Graft Effectiveness
The study examines the impact of silymarin supplementation during the early post-transplant period, administering 900 g daily for 30 days under standard treatment.
- Conditions
- Posttransplant Diabetes Mellitus, Acute Graft Rejection, Biopsy Proven Acute Rejection, Antibody Mediated Rejection of Kidney Transplant
- Trial name
- SAGE (NCT06801886)
- Testing
- Silymarine supplementation
- Where
- Slovakia
- Volunteers
- 130 people
- Sponsor
- University Hospital, Martin
Renal Transplant Recipients, Posttransplant Diabetes Mellitus
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
The objective of the present study is to evaluate both the efficacy and safet of nateglinide in renal transplanta recipients with posttransplant diabetes mellitus or impaired glucose tolerance.
- Conditions
- Renal Transplant Recipients, Posttransplant Diabetes Mellitus, Posttransplant Impaired Glucose Tolerance
- Trial name
- NCT00319189
- Testing
- Nateglinide
- Where
- Norway
- Volunteers
- 15 people
- Sponsor
- University of Oslo School of Pharmacy
Posttransplant Diabetes Mellitus
Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant
The purpose of this study is to determine whether sitagliptin is effective in preventing the development of new-onset diabetes after kidney transplant (NODAT).
- Trial name
- NCT01928199
- Testing
- Sitagliptin
- Where
- United States
- Volunteers
- 61 people
- Sponsor
- Washington University School of Medicine
Posttransplant Diabetes Mellitus
Empagliflozin in Post-Transplantation Diabetes Mellitus
RELEVANCE: Up to 50% of patients without previously known disorders of glucose metabolism develop posttransplantation diabetes mellitus (PTDM) after renal transplantation, which is associated with cardiovascular events.
- Trial name
- EMPTRA-DM (NCT03113110)
- Testing
- Empagliflozin 10 mg
- Where
- Austria
- Volunteers
- 16 people
- Sponsor
- Medical University of Vienna
Posttransplant Diabetes Mellitus
Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)
Posttransplantation diabetes mellitus after kidney transplantation mediated by tacrolimus is mainly dependent on dose and peak plasma concentration.
- Trial name
- TAGLUMET (NCT05396898)
- Testing
- LCP-tacrolimus, twice-daily tacrolimus
- Where
- Germany
- Volunteers
- 44 people
- Sponsor
- University Hospital Tuebingen
Diabetes Mellitus, Kidney Transplantation
Influence of Pioglitazone for Renal Transplant Function in Diabetics
The purpose of this study is to test whether pioglitazone is able to prevent the progression of diabetic nephropathy in kidney transplant recipients with diabetes mellitus.
- Conditions
- Diabetes Mellitus, Kidney Transplantation, Proteinuria
- Trial name
- NCT00507494
- Testing
- pioglitazone
- Where
- Germany
- Sponsor
- Technische Universität Dresden
Post-transplant Diabetes Mellitus, Kidney Transplant; Complications
Define Predictors for Posttransplant Diabetes Mellitus Study
The primary aim of this prospective, multicentre study is to develop an accurate and convenient tool to predict the risk of PTDM at 3 months post-transplant, based on information on the day of transplantation (day 0).
- Trial name
- DECODE (NCT06440330)
- Testing
- continuous glucose monitoring
- Where
- Belgium
- Volunteers
- 330 people, healthy volunteers welcome
- Sponsor
- University Hospital, Antwerp
Diabetes Mellitus, Kidney Transplant
Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA
The study aims to improve the prediction and early detection of post-transplant diabetes mellitus (PTDM) in kidney transplant recipients.
- Trial name
- POD-MIR (NCT07055984)
- Where
- 2 sites in Slovakia
- Volunteers
- 130 people
- Sponsor
- University Hospital, Martin